InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Hungerford Brian. Director active across 1 company, notably Kiromic Biopharma, Inc.. Cumulatively, 5 disclosures have been recorded. Split: 4 buys · 0 sell. Total volume traded: €9k. History available since 3 May 2024. The latest transaction was filed on 19 August 2024 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Hungerford Brian is a declarant with 5 filings in total. In the 5 most recent filings available, all related to Kiromic Biopharma, Inc., market XNAS, the transactions are acquisitions, with EUR 9,068 of buys and EUR 0 of sells between 2024-05-07 and 2024-08-21. His listed role at the company is Chief Financial Officer.